MDR tuberculosis and non-compliance with therapy.

نویسندگان

  • Suheir Ereqat
  • Mark Spigelman
  • Gila Kahila Bar-Gal
  • Asad Ramlawi
  • Ziad Abdeen
چکیده

178 www.thelancet.com/infection Vol 12 March 2012 3 World Health Organization. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drugresistant tuberculosis by 2015: WHO progress report 2011. http://whqlibdoc.who.int/ publications/2011/9789241501330_eng.pdf (accessed Mar 24, 2011). 4 Upshur R, Singh J, Ford N. Apocalypse or redemption: responding to extensively drug-resistant tuberculosis. Bull World Health Organ 2009; 87: 481–83. 5 London L. Confi nement for extensively drug-resistant tuberculosis: balancing protection of health systems, individual rights and the public’s health. Int J Tuberc Lung Dis 2009; 13: 1200–09. required, that might reduce the risk of transmission to others, as is being attempted in South Africa. As case detection and treatment for MDR tuberculosis is scaled up internationally, how to care for patients who have exhausted all treatment options with existing second-line drugs will become increasingly important. Currently, no third-line treatment for tuberculosis exists. Until newer drugs become available, we will need to care for such patients in a manner that balances the risk of ongoing transmission with individual human rights. The health system must still support patients in whom treatment has failed. The provision of homebased palliative care, for example, is likely to be more humane and less costly to health services compared with involuntary detention. Although a small proportion of patients might realistically be classifi ed as recalcitrant, and legal means may be necessary to restrict transmission, we feel that every eff ort should be made to support patients, either to continue treatment if they so wish, or to live out the remainder of their lives in a manner that minimises the risk of transmission to others. In this case, the threat of incarceration is also likely to further reduce the chances that this patient will be located. We feel that such patients should not be managed by an automatic resort to legal coercion.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Isoniazid resistant TB and non-compliance.

We read with interest the report by Ruddy et al on the outbreak of isoniazid resistant tuberculosis in North London. We share their concern about the development of multidrug resistant tuberculosis (MDR-TB) in patients infected with a Mycobacterium tuberculosis strain with primary isoniazid resistance which may occur especially in cases of noncompliance. In the Netherlands the incidence of TB i...

متن کامل

Extensively drug-resistant tuberculosis: epidemiology and management

The advent of antibiotics for the treatment of tuberculosis (TB) represented a major breakthrough in the fight against the disease. However, since its first use, antibiotic therapy has been associated with the emergence of resistance to drugs. The incorrect use of anti-TB drugs, either due to prescription errors, low patient compliance, or poor quality of drugs, led to the widespread emergence ...

متن کامل

تشخیص سریع مایکوباکتریوم‌های آتیپیک در بیماران با علایم سل ریوی: ارزیابی لوکوس (QUB 3232 (590bp با روش VNTR

Background and Objective: Identification of atypical mycobacterium (Non tuberculosis Mycobacterium NTM) is important because of the worldwide propagation of these organisms. Recently, molecular studies have identified the specific loci for mycobacterium species by DNA - finger printing methods, but these methods are time-consuming and expensive. In this study, in addition to hsp65 PCR-RFLP meth...

متن کامل

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China

BACKGROUND We conducted a cohort study to compare the characteristics of MDR-TB with non-MDR-TB patients and to measure long term (9-year) mortality rate and determine factors associated with death in China. METHODS We reviewed the medical records of 250 TB cases from a 2001 survey to compare 100 MDR-TB patients with 150 non-MDR-TB patients who were treated in 2001-2002. Baseline attributes e...

متن کامل

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis

Introduction: The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gov...

متن کامل

Clinical Evaluation of Tuberculosis Viability Microscopy for Assessing Treatment Response

BACKGROUND It is difficult to determine whether early tuberculosis treatment is effective in reducing the infectiousness of patients' sputum, because culture takes weeks and conventional acid-fast sputum microscopy and molecular tests cannot differentiate live from dead tuberculosis. METHODS To assess treatment response, sputum samples (n=124) from unselected patients (n=35) with sputum micro...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Lancet. Infectious diseases

دوره 11 9  شماره 

صفحات  -

تاریخ انتشار 2011